Research gaps Despite considerable progress, important research gaps remain
Bone-specific alkaline phosphatase (BALP) is the foremost component in the course of calcification process of the matrix 18,19
Tirzepatide (Mounjaro, Zepbound) is an FDA-approved medication for type 2 diabetes and chronic weight management that commonly causes gastrointestinal side effects
It contains sterile water mixed with a small amount of preservative
Retatrutide adds glucagon receptor activation to the GIP and GLP-1 effects seen with tirzepatide
10.1080/0886022X.2024.2441398 Summary Keywords gout, hyperuricemia, drug delivery systems, therapeutic, prospect Citation Peng Z, Meng F, Deng Q, Huang Y, Mao D, Long Y, Yan W, Peng J, Wang X and Liu N (2025) Advances in drug delivery systems for the management of gout and hyperuricemia